Metraipolis › archive › dc_cd0805151a8f
Gamma-glutamyl metformin inhibits renal cell carcinoma progression by activating AMPK signaling pathway — Europe PMC PMID:42181886
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42181886
- DOI
- 10.3389/fphar.2026.1807987
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T16:34:53.870Z
- SHA-256 of the archived text
96c34269e205b841347b67f322ab31c180512e0226126a15d39daaccf3f07cbd- Stable URL of this page
https://metraipolis.com/documento/dc_cd0805151a8f
How to cite
Gamma-glutamyl metformin inhibits renal cell carcinoma progression by activating AMPK signaling pathway — Europe PMC PMID:42181886 — Europe PMC (en), https://europepmc.org/article/MED/42181886 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd0805151a8f (Metraipolis archive dc_cd0805151a8f, sha256 96c34269e205b841347b67f322ab31c180512e0226126a15d39daaccf3f07cbd)
BibTeX
@misc{dccd0805151a8f,
title = {Gamma-glutamyl metformin inhibits renal cell carcinoma progression by activating AMPK signaling pathway — Europe PMC PMID:42181886},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42181886},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd0805151a8f; sha256 96c34269e205b841347b67f322ab31c180512e0226126a15d39daaccf3f07cbd},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42181886. Agents can read the archived copy with the MCP tool read_document.